In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more

The clinical presentation of “angina pectoris” in women

Cardiovascular disease in women is the number one cause of death worldwide. Women and men have different patterns of ischaemic heart disease (IHD) throughout their lifetime. In clinical cardiology, the male obstructive pattern of coronary artery disease (CAD) dominates in risk assessment, symptom evaluation, diagnostic testing and therapy. Women have more non-obstructive CAD and functional IHD in the coronary (micro-)circulation, which is often underdiagnosed and undertreated. Different patterns of IHD translate into different symptoms of angina between genders. A better understanding of typical female symptoms of angina and a more female-tailored risk stratification will lead to earlier recognition, optimal treatment and better outcomes of IHD in women.

Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care


Women have distinct patterns of ischaemic heart disease (IHD)

Women have a smaller diameter of the coronary arteries than men, when corrected for body surface area. Postmortem studies and CT angiograms show clinically relevant sex differences in plaque morphology with women having fewer calcifications, less focal obstruction and a more diffuse pattern of atherosclerosis with “outward remodelling” and “soft” plaques than men at all ages (Figure 1) [1,2]. Combined structural and functional disorders of the coronary (micro-) circulation are involved in the various manifestations of IHD [3]. In women, at middle age “functional IHD” is far more prevalent than obstructive coronary artery disease (CAD), which presents at an earlier age in men. In patients with non-obstructive coronary artery disease (NOCAD) at coronary angiography, lesions up to 20% can be present without being noticed, whereas intravascular ultrasound (IVUS) reveals the presence of atherosclerosis [4]. In clinical practice, IVUS is not regularly carried out in these patients and their symptoms are often misinterpreted as being of non-cardiac origin, resulting in undertreatment of symptoms and risk factors. Despite this, NOCAD has a higher five-year event rate in symptomatic women than in men, especially when signs of ischaemia are present [5]. As many cardiologists are still mainly focused on obstructive CAD in the epicardial coronary arteries, more attention is needed to recognise better the more diverse manifestations of IHD in women.

Figure 1. Female pattern of ischaemic heart disease

V15n03-Figure1.jpg

 Symptoms of stable angina in women

The clinical evaluation of symptoms of angina pectoris in women is still considered according to the male standard. Risk estimation charts in the guidelines are primarily based on diagnosing obstructive CAD. In selected patients undergoing PCI for single-vessel disease, the main symptoms of angina are not different among men and women [6]. However, this selection bias in coronary lesions does not reflect daily practice. Whereas classic angina symptoms are more related to obstructive CAD, the combination of NOCAD with endothelial dysfunction frequently occurs in young and middle-aged women, with a more atypical symptom presentation. These symptoms occur both at rest and during exercise and may vary over time. Endothelial dysfunction and coronary spasm fluctuate within days/weeks and may present in a crescendo/decrescendo pattern. Stressful events often aggravate the duration and intensity of symptoms. Gender differences in communication frequently hamper the early recognition of angina in women. Women's communication is more likely to be emotional, subjective, polite, and self-revealing with more concern and awareness for the feelings of others. Men usually report their symptoms in a direct way, while female patients ask more questions, present more and diverse symptoms and give more detailed histories of their activities. This can be misleading to both female patients and their doctors for the correct interpretation of symptoms of IHD. The diverse symptoms of stable angina in women are depicted in Table 1.

 

Table 1. Classification of angina with female-specific aspects (♀)

Classification of angina

Criteria + female specific aspects

Typical angina (definite)

Meets 3 of the following characteristics:

·         oppressive substernal chest discomfort

·         provoked by exertion or emotional stress

·         relieved by rest and/or nitrates within minutes

 

♀     squeezing, tight, chest discomfort

♀     radiation to chest, jaw(s), left armpit and/or left arm,

 neck, shoulders and inter-scapular area

♀     may last longer than minutes

♀     crescendo/decrescendo character (spasm)

♀     dyspnoea, anxiety, mental stress-related

♀     extreme tiredness, also often after angina episode

Atypical angina (probable)

Meets 2 criteria

♀     both typical and atypical symptoms in NOCAD

 

Non-anginal chest pain

Lacks or meets only one characteristic criterion

♀     beware of cardiac anxiety disorder

Adapted with permission from Montalescot G et al, 2013 ESC guidelines stable CAD [7].

Coronary microvascular disease (CMD)

In many women with “normal” coronary arteries, recurrent angina is frequently provoked by exercise, suggesting obstructive CAD. However, the presence of coronary microvascular disease (CMD) is more likely if there is a variable threshold of physical activity that provokes angina, if the chest pain persists for several minutes after effort is interrupted and/or if there is a slow or poor response to short-acting nitrates [7,8]. In addition to exercise-induced angina, (prolonged) chest pain at rest and/or at night/early morning is often reported, which may be provoked by vasospasm. Also, low heart rate activities such as mental arousal or palpitation are more common triggers of angina than in patients with obstructive atherosclerosis [9]. In many patients, dyspnoea on exertion is also reported to be an equivalent of a disturbed oxygen demand, with a general feeling of tiredness and loss of energy. Women with CMD often have concentration problems and are more prone to work-related problems and “burn-out”.

How to identify the female patient at risk for premature IHD

Symptom evaluation alone is not sufficient to distinguish angina pectoris related to endothelial dysfunction/ischaemia from non-cardiac causes of chest pain. The presence of traditional risk factors (RF), female-specific RF and non-traditional risk variables may importantly add to the likelihood of IHD. A positive family risk is an even stronger risk factor for women than for men and importantly adds to risk prediction at a younger age [10]. Migraine is related to an increased family risk for CVD, premature vascular dysfunction and a higher susceptibility for thrombosis and inflammation [11]. Reproductive and pregnancy-related factors predispose to earlier signs of endothelial dysfunction, vascular inflammation and atherosclerosis [12]. In a recent meta-analysis among the various reproductive RF that are known, a previous history of preeclampsia/HELLP was found to be the strongest RF for CVD, with a twofold higher risk [13]. This has now also been incorporated in the 2016 ESC guidelines on CVD prevention [14]. When women are in their forties/early fifties, inflammatory diseases often occur, such as inflammatory bowel disease, thyroid disorders, the metabolic syndrome and rheumatic disorders. These are non-traditional risk variables that may add to a higher susceptibility for endothelial dysfunction [15]. The horizontal life course of women who are more prone to premature signs of IHD is depicted in Figure 2. At older age (>65 years), the traditional RF apparently overrule the abovementioned RF with a shift in the pattern of IHD to more obstructive disease. In parallel, angina symptoms may become more “typical”. However, elderly women often have RF that may enhance diastolic dysfunction, with concomitant symptoms of dyspnoea on exertion. These symptoms can interfere with symptoms of angina and make the diagnosis difficult. The impact of vascular dysfunction and spasm is presumed to decrease at older age, when vascular stiffness and atherosclerosis are more extensively developed.

 

Figure 2. Female-specific and non-traditional risk factors: risk variables for early endothelial dysfunction/premature CVD.

V15n03-Figure 2.jpg

ACS: acute coronary syndromes; CMD: coronary microvascular dysfunction; CVD: cardiovascular disease; GDM: gestational diabetes mellitus; HELLP: haemolysis, elevated liver enzymes and low platelets syndrome; HPD: hypertensive pregnancy disorders; PCOS: polycystic ovary syndrome; VMS: vasomotor symptoms

Conclusion

Women have different manifestations of IHD during their lifetime.

At younger age, NOCAD and coronary (micro-)vascular dysfunction predominate over obstructive CAD, resulting in a different symptom presentation.

Female-specific RF and non-traditional risk variables may contribute to identifying younger women at increased CVD risk.

Doctors should be aware of the different communication styles among men and women.

References


  1. Smilowitz NR, Sampson BA, Abrecht CR, Siegfried JS, Hochman JS, Reynolds HR. Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. Am Heart J. 2011 Apr;161(4):681-8. 
  2. Nasir K, Gopal A, Blankstein R, Ahmadi N, Pal R, Khosa F, Shaw LJ, Blumenthal RS, Budoff MJ. Noninvasive assessment of gender differences in coronary plaque composition with multidetector computed tomographic angiography. Am J Cardiol. 2010 Feb 15;105(4):453-8. 
  3. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009 Oct 20;54(17):1561-75. 
  4. Lee, B.K, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015 Mar 24;131(12):1054-60. 
  5. Sedlak TL, Lee M, Izadnegahdar M, Merz CN, Gao M, Humphries KH. Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J. 2013 Jul;166(1):38-44. 
  6. Kreatsoulas C, Shannon HS, Giacomini M, Velianou JL, Anand SS. Reconstructing angina: cardiac symptoms are the same in women and men. JAMA Intern Med. 2013 May 13;173(9):829-31. 
  7. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013 Oct;34(38):2949-3003. 
  8. Ong P, Athanasiadis A, Sechtem U. Pharmacotherapy for coronary microvascular dysfunction. Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):65-71.
  9. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014 May;35(17):1101-11. 
  10. Patel MJ, de Lemos JA, Philips B, Murphy SA, Vaeth PC, McGuire DK, Khera A. Implications of family history of myocardial infarction in young women. Am Heart J. 2007 Sep;154(3):454-60. 
  11. Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB, Willett WC, Manson JE, Rexrode KM. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016 May 31;353:i2610. 
  12. Veerbeek JH, Hermes W, Breimer AY, van Rijn BB, Koenen SV, Mol BW, Franx A, de Groot CJ, Koster MP. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015 Mar;65(3):600-6. 
  13. Heida KY, Bots ML, de Groot CJ, van Dunne FM, Hammoud NM, Hoek A, Laven JS, Maas AH, Roeters van Lennep JE, Velthuis BK, Franx A. Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol. 2016 Nov;23(17):1863-1879. 
  14. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315-81. 
  15. Elias-Smale SE, Günal A, Maas AH. Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women. Maturitas. 2015 Jul;81(3):348-52.

Notes to editor


Prof. Dr Angela H.E.M. Maas, MD, PhD, FESC

Director Women’s Cardiac Health Program, Department of Cardiology, Radboudumc, Nijmegen, The Netherlands

 

Address for correspondence:

Radboudumc, department of Cardiology, route 616

Geert Groteplein-Zuid 10

6525GA Nijmegen, The Netherlands

Phone 0031 24 3614533

E-mail: Angela.Maas@radboudumc.nl

 

Author disclosures:

The author has no conflicts of interest to declare.

 

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.